Description

Thiogamma Turbo (α-lipoic acid) solution for infusions 1.2% 50 ml. №10 vial

Ingredients:

Thiogamma Turbo contains α-lipoic acid as the active ingredient. Other ingredients include water for injections.

Dosage:

Thiogamma Turbo is administered through intravenous infusion. The recommended dosage is determined by a healthcare professional based on the patient’s condition and needs.

Indications:

Thiogamma Turbo is indicated for the treatment of diabetic neuropathy and other conditions where alpha-lipoic acid supplementation is necessary.

Contraindications:

Thiogamma Turbo is contraindicated in patients with known hypersensitivity to alpha-lipoic acid or any of the other ingredients in the solution.

Directions:

Thiogamma Turbo should be administered by healthcare professionals following the recommended infusion protocol. It is essential to adhere to proper aseptic techniques during administration.

Scientific Evidence:

Studies have shown that alpha-lipoic acid, the active ingredient in Thiogamma Turbo, possesses antioxidant properties and plays a role in mitigating oxidative stress in various disease states. Research published in the “International Journal of Molecular Sciences” highlights the neuroprotective effects of alpha-lipoic acid in diabetic neuropathy by reducing oxidative stress and inflammation.

Additional Information:

Thiogamma Turbo is a well-tolerated treatment option with a favorable safety profile. It is essential to monitor patients for any signs of adverse reactions during and after infusion. Consult a healthcare professional for personalized recommendations.

Alpha-lipoic acid, the key component of Thiogamma Turbo, acts as a cofactor for mitochondrial enzymes involved in energy production. Its antioxidant properties help in scavenging free radicals and regenerating other antioxidants, making it a valuable therapeutic agent in various oxidative stress-related conditions.

Clinical trials have demonstrated the efficacy of alpha-lipoic acid in improving symptoms of diabetic neuropathy and reducing neuropathic pain. A study published in the “Journal of Diabetes and its Complications” reported significant improvements in nerve conduction velocity and neuropathic symptoms in patients treated with alpha-lipoic acid, supporting its use in the management of diabetic neuropathy.